Skip to content

Clinical trials

Completed Pulmonary Fibrosis trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Fibrosis Status: Completed Country / region: United States Clear all

55 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20021
20032
20041
20052
20062
20073
20084
20091
20102
20117
20136
20142
20151
20162
20183
20191
20205
20211
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed55

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Heart, Lung, and Blood Institute (NHLBI)8
Boehringer Ingelheim3
National Jewish Health3
Duke University2
Kyntra Bio2
National Human Genome Research Institute (NHGRI)2
National Institute of Allergy and Infectious Diseases (NIAID)2
University of California, San Francisco2
VA Office of Research and Development2
23andMe, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Fibrosis55
Idiopathic Pulmonary Fibrosis24
Lung Diseases, Interstitial15
Lung Diseases9
Hypertension, Pulmonary7
Pulmonary Disease, Chronic Obstructive6
Dyspnea4
Fibrosis4
Sarcoidosis4
Cystic Fibrosis3

Trials

Showing 1 to 25 of 55. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.